Chunhua Weng

1.0k total citations · 1 hit paper
24 papers, 668 citations indexed

About

Chunhua Weng is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Chunhua Weng has authored 24 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Nephrology and 7 papers in Cancer Research. Recurrent topics in Chunhua Weng's work include MicroRNA in disease regulation (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Chunhua Weng is often cited by papers focused on MicroRNA in disease regulation (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Chunhua Weng collaborates with scholars based in China, United States and Madagascar. Chunhua Weng's co-authors include Xiujin Shen, Hong Jiang, Jianghua Chen, Haibing Wang, Zhengping Xu, Haojie Dong, Rongpan Bai, Guangdi Chen, Jianghua Chen and Cuili Wang and has published in prestigious journals such as International Journal of Cancer, Acta Biomaterialia and Nutrients.

In The Last Decade

Chunhua Weng

21 papers receiving 661 citations

Hit Papers

Caspase 3/GSDME-dependent pyroptosis contributes to chemo... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunhua Weng China 15 388 173 139 116 79 24 668
Yoo Hyung Kim South Korea 11 470 1.2× 195 1.1× 90 0.6× 72 0.6× 78 1.0× 22 935
Piera Trionfini Italy 10 496 1.3× 304 1.8× 170 1.2× 105 0.9× 56 0.7× 19 798
Hongwen Zhang China 16 366 0.9× 66 0.4× 144 1.0× 72 0.6× 56 0.7× 67 731
Weiwei Shen China 14 297 0.8× 177 1.0× 75 0.5× 59 0.5× 50 0.6× 25 570
Mingqi Tan China 13 436 1.1× 76 0.4× 83 0.6× 98 0.8× 60 0.8× 19 720
Eun-Jin Yeo United States 8 482 1.2× 305 1.8× 124 0.9× 208 1.8× 55 0.7× 9 909
Xian Xue China 11 304 0.8× 85 0.5× 154 1.1× 183 1.6× 30 0.4× 16 649
Asta Valančiūtė France 11 281 0.7× 106 0.6× 215 1.5× 124 1.1× 28 0.4× 15 706
Mitsumi Arito Japan 14 284 0.7× 88 0.5× 37 0.3× 120 1.0× 58 0.7× 44 579

Countries citing papers authored by Chunhua Weng

Since Specialization
Citations

This map shows the geographic impact of Chunhua Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunhua Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunhua Weng more than expected).

Fields of papers citing papers by Chunhua Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunhua Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunhua Weng. The network helps show where Chunhua Weng may publish in the future.

Co-authorship network of co-authors of Chunhua Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Chunhua Weng. A scholar is included among the top collaborators of Chunhua Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunhua Weng. Chunhua Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Yuhan, Yanshan Wang, Yunyu Xiao, et al.. (2025). Machine learning applications related to suicide in military and Veterans: A scoping literature review. Journal of Biomedical Informatics. 167. 104848–104848.
3.
Feng, Wenjie, Chunhua Weng, Li Chen, et al.. (2025). Omeprazole-mediated nanodelivery of copper for synchronous remodeling of copper influx and efflux in cuproptotic glioblastoma therapy. Acta Biomaterialia. 210. 499–515.
4.
Zhang, Yunjing, Jicheng Wu, Quanlin An, et al.. (2023). Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD. Nano Research. 16(7). 9701–9714. 4 indexed citations
5.
Weng, Chunhua, Haojie Dong, Rongpan Bai, et al.. (2022). Angiogenin promotes angiogenesis via the endonucleolytic decay of miR-141 in colorectal cancer. Molecular Therapy — Nucleic Acids. 27. 1010–1022. 12 indexed citations
6.
Weng, Chunhua, et al.. (2022). Characterization and Function of the Interaction of Angiogenin With Alpha-Actinin 2. Frontiers in Molecular Biosciences. 9. 837971–837971. 4 indexed citations
7.
Zhang, Yunjing, Qiongzi Qiu, Yuan Yuan, et al.. (2022). Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis. International Journal of Biological Sciences. 18(4). 1491–1507. 16 indexed citations
8.
Zhu, Huanhuan, Junni Wang, Chunhua Weng, et al.. (2022). Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus. Nutrients. 14(16). 3345–3345. 27 indexed citations
9.
Shen, Xiujin, Haibing Wang, Chunhua Weng, Hong Jiang, & Jianghua Chen. (2021). Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death and Disease. 12(2). 186–186. 165 indexed citations breakdown →
10.
Dong, Lihua, Jing Qin, Wenyu Xiang, et al.. (2020). ADAM10 mediates ectopic proximal tubule development and renal fibrosis through Notch signalling. The Journal of Pathology. 252(3). 274–289. 19 indexed citations
11.
Chen, Wenqing, Chong Luo, Yucheng Wang, et al.. (2019). The pathogenic AGT c.856+1G>T mutation of a patient with multiple renal cysts and hypertension. Annals of Translational Medicine. 7(22). 699–699. 2 indexed citations
12.
Jiang, Hong, Xue Shao, Chunhua Weng, et al.. (2019). The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease. Cellular Physiology and Biochemistry. 52(2). 156–171. 61 indexed citations
13.
Dong, Haojie, Chunhua Weng, Rongpan Bai, et al.. (2018). The regulatory network of miR-141 in the inhibition of angiogenesis. Angiogenesis. 22(2). 251–262. 40 indexed citations
14.
Zhang, Jian, et al.. (2018). Urinary C‑X‑C motif chemokine 13 is a noninvasive biomarker of antibody‑mediated renal allograft rejection. Molecular Medicine Reports. 18(2). 2399–2406. 8 indexed citations
15.
Shao, Xue, Luxi Cao, Yucheng Wang, et al.. (2017). Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis. Oncotarget. 8(28). 46436–46448. 22 indexed citations
16.
Shen, Jia, Rending Wang, Hongfeng Huang, et al.. (2016). NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42‐GTP activation in podocytes. The Journal of Pathology. 240(2). 149–160. 26 indexed citations
17.
Bai, Rongpan, Chunhua Weng, Haojie Dong, et al.. (2015). MicroRNA‐409‐3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression. International Journal of Cancer. 137(10). 2310–2322. 64 indexed citations
18.
Hassid, Benjamin, Aimee L. Lucas, Marcela Salomao, et al.. (2014). Absence of Pancreatic Intraepithelial Neoplasia Predicts Poor Survival After Resection of Pancreatic Cancer. Pancreas. 43(7). 1073–1077. 18 indexed citations
19.
Weng, Chunhua, Haojie Dong, Guangdi Chen, et al.. (2012). miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Letters. 323(2). 171–179. 56 indexed citations
20.
Zhang, Hui, Xiangwei Gao, Chunhua Weng, & Zhengping Xu. (2008). Interaction between angiogenin and fibulin 1: evidence and implication. Acta Biochimica et Biophysica Sinica. 40(5). 375–380. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026